[Retracted] mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9

Figure 4

miR-126-5p promotes cisplatin sensitivity of NSCLC cells and apoptosis and reduces cell viability via ADAM9: (a, b) MTT assay-based detection of IC50 for cisplatin in miR-126-5+con and miR-126-5p+ADAM9 groups; (c) quantitative analysis of IC50 for cisplatin in the indicated cells; (d) colony formation assay-based detection of the proliferation of the indicated cells in the two groups; (e) flow cytometry-based detection of apoptosis in the indicated cells in the two groups.

(a)

(b)

(c)

(d)

(e)